We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Rapid Molecular Assays Detects Yellow Fever Virus

By LabMedica International staff writers
Posted on 24 Mar 2014
Print article
Image: Electron micrograph of yellow fever virions (Photo courtesy of Dr. Erskine Palmer).
Image: Electron micrograph of yellow fever virions (Photo courtesy of Dr. Erskine Palmer).
A nucleic acid detection method has been developed to detect the Yellow fever virus (YFV) which would be easy to perform in low-resources settings.

Rapid and reliable diagnostic methods that are simple to execute could have a major impact on early detection of outbreaks and implementation of appropriate response strategies such as vaccination and/or vector control.

Scientists at the Robert Koch Institute (Berlin, Germany) working with an international team of collaborators, adopted an isothermal approach and developed a recombinase polymerase amplification (RPA) assay which can be performed with a small portable instrument and easy-to-use lyophilized reagents. The assay was developed in three different formats, real-time with or without microfluidic semi-automated system and lateral-flow assay to evaluate their application for different purposes.

Viral ribonucleic acid (RNA) was isolated from of cell culture supernatants or aliquots of mosquito pools, using the QIAamp Viral Mini Kit (QIAGEN Lake Constance GmbH; Stockach, Germany). The assay to detect and quantify genomic RNA of YFV was performed in a one-step format on the ABI 7500 instrument (Life Technologies; Carlsbad, CA, USA) using the Qiagen’s QuantiTect Virus Kit. Lateral-flow strip real time (RT)-RPA assay was performed using the TwistAmp nfo RT kit from TwistDx (Cambridge, UK). Centrifugal microfluidic cartridges, termed GeneSlice (HSG-IMIT, Lab on a Chip Design- and Foundry Service; Freiburg, Germany), were used to demonstrate process automation of real-time RT-RPA in a small and portable processing device, the “SONDE” player, that may be used in the field with minimum manual interaction.


The authors found that the RT-RPA assay for YFV detection can be performed without complex equipment in a basic laboratory setting, a rural health care center or an outbreak field investigation. Real-time RT-RPA results demonstrated an optimal specificity. The authors concluded that the real-time RT-RPA assay, using the transportable Tube Scanner device combined with the RNA extraction method based on magnetic beads, and the use of lyophilized reagents which can be stored at ambient temperature allowed the application of the RPA assay under field conditions in Senegal with performance similar to that of cutting-edge laboratory settings. The study was published on March 6, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Robert Koch Institute 
QIAGEN
Life Technologies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.